Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Williams, Bryan, Prof, MacDonald, Thomas M, Prof, Morant, Steve, PhD, Webb, David J, Prof, Sever, Peter, Prof, McInnes, Gordon, Prof, Ford, Ian, Prof, Cruickshank, J Kennedy, Prof, Caulfield, Mark J, Prof, Salsbury, Jackie, Prof, Mackenzie, Isla, FRCP, Padmanabhan, Sandosh, FRCP, Brown, Morris J, Prof
Published in The Lancet (British edition) (21.11.2015)
Published in The Lancet (British edition) (21.11.2015)
Get full text
Journal Article
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
Brown, Morris J, Prof, Williams, Bryan, Prof, Morant, Steve V, PhD, Webb, David J, Prof, Caulfield, Mark J, Prof, Cruickshank, J Kennedy, Prof, Ford, Ian, Prof, McInnes, Gordon, Prof, Sever, Peter, Prof, Salsbury, Jackie, RGN, Mackenzie, Isla S, FRCP, Padmanabhan, Sandosh, FRCP, MacDonald, Thomas M, Prof
Published in The lancet. Diabetes & endocrinology (01.02.2016)
Published in The lancet. Diabetes & endocrinology (01.02.2016)
Get full text
Journal Article